WSC
EXAS

Wellington Shields & Co’s Exact Sciences EXAS Stock Holding History

Wellington Shields & Co’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-6,153
Closed -$455K – 306
2023
Q4 		$455K Sell
6,153
-905
-13% -$59.3K 0.17% 122
2023
Q3 		$481K Buy
7,058
+250
+4% +$21.2K 0.12% 121
2023
Q2 		$639K Hold
6,808
– – 0.15% 94
2023
Q1 		$462K Buy
6,808
+3,750
+123% +$241K 0.1% 125
2022
Q4 		$151K Buy
+3,058
New +$125K 0.03% 223

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wellington Shields & Co's EXAS Position: Q1 2024 in Review

Wellington Shields & Co sold out of Exact Sciences (EXAS) in Q1 2024, closing a stake of 6,153 shares — an estimated $455K sold.

Wellington Shields & Co first reported a position in EXAS in Q4 2022 and held it in 5 quarters. The position peaked at $639K in Q2 2023. 625 funds tracked by Wall St. Rank hold EXAS as of Q1 2024.

  • Wellington Shields & Co reported no remaining Exact Sciences position as of Q1 2024 after selling out during the quarter.
  • Wellington Shields & Co sold 6,153 Exact Sciences shares in Q1 2024, an estimated $455K.
  • Wellington Shields & Co first reported a position in Exact Sciences in Q4 2022 and held it in 5 quarters.
  • Wellington Shields & Co's Exact Sciences position peaked at $639K in Q2 2023.
  • 625 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2024.

Based on Wellington Shields & Co's 13F filing for Q1 2024, filed 3 May 2024.